Against Russia which, she said, has repeatedly delayed the European Medicines Agency (EMA) inspections needed to certify its COVID-19 vaccine against Sputnik V in the European Union, its ambassador turned to on Friday (8/10). EU in Moscow.
The Russian coronavirus vaccine Sputnik V, which is widely used in the country and approved for use in more than 70 countries, is being evaluated by the World Health Organization and the EMA as required to be approved for purchases outside Russia.
Russia is turning against the West and blaming it
Russia accuses the West of refusing to certify its main vaccine for political reasons. Without EMA approval, it is more difficult for Russians to travel to the EU.
“It is a technical rather than a political process,” EU Ambassador Markus Enterer said in an interview with Russia’s RBC media group.
“When Russian officials talk about delaying and politicizing the process on the European side, I sometimes think they are referring primarily to themselves because they are the ones doing it for politics,” he was quoted as saying by the Athens News Agency.
The Russian Foreign Investment Fund (RDIF), which trades abroad Sputnik V, declined to comment.
The EMA, for its part, said it could not comment at this time.
Five people familiar with European efforts to evaluate the drug told Reuters this year that the makers of Sputnik V did not provide information that regulators consider to be standard requirements for the drug approval process.
RDIF said at the time that the Reuters report contained “false and inaccurate statements” based on anonymous sources trying to undermine Sputnik V as part of a misinformation campaign.
What the Russian Minister of Health said
Russian Health Minister Mikhail Murasko said this month that all obstacles to the registration of Sputnik V in the WHO. have been removed leaving only some documents to be completed.
According to the TASS news agency, the Ministry of Health said today that EMA inspectors may visit Russia in December.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
